A Trial of CP101 for the Prevention of Recurrent CDI (PRISM4)

NCT05153499 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
19
Enrollment
INDUSTRY
Sponsor class

Stopped The termination of FIN-CDI-301 (PRISM4) is based on the voluntary, business-related decision of the sponsor.

Conditions

Interventions

Sponsor

Finch Research and Development LLC.